Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients

Published:2012-07-10 Issue:6 Volume:36 Page:569-574
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Mohabbat A. B.¹,Sandborn W. J.²,Loftus E. V.³,Wiesner R. H.³,Bruining D. H.³

Affiliation:

1. Department of Internal Medicine; Mayo Clinic College of Medicine; Rochester; MN; USA

2. Division of Gastroenterology; University of California San Diego; La Jolla; CA; USA

3. Division of Gastroenterology and Hepatology; Mayo Clinic College of Medicine; Rochester; MN; USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2012.05217.x/fullpdf

Reference18 articles.

1. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis;Olsson;Gastroenterology,1991

2. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis;Papatheodoridis;Gut,1998

3. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation;Ho;Eur J Gastroenterol Hepatol,2005

4. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation;Miki;Br J Surg,1995

5. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease;Verdonk;Am J Transplant,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant;Journal of Clinical Gastroenterology;2024-08-14

2. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship;Minerva Gastroenterology;2024-02

3. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement;Transplant International;2023-09-29

4. Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis;Inflammatory Bowel Diseases;2023-06-10

5. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks;Inflammatory Bowel Diseases;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3